Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

BUY
$161.01 - $317.85 $1.66 Million - $3.28 Million
10,334 Added 24.87%
51,891 $16.4 Million
Q3 2023

Nov 09, 2023

SELL
$164.66 - $218.08 $3.66 Million - $4.84 Million
-22,207 Reduced 34.83%
41,557 $7.03 Million
Q2 2023

Aug 09, 2023

SELL
$176.32 - $240.22 $481,882 - $656,521
-2,733 Reduced 4.11%
63,764 $13.8 Million
Q1 2023

May 12, 2023

SELL
$161.33 - $204.36 $10.5 Million - $13.4 Million
-65,331 Reduced 49.56%
66,497 $12.1 Million
Q4 2022

Feb 09, 2023

BUY
$191.53 - $236.82 $2.1 Million - $2.6 Million
10,963 Added 9.07%
131,828 $25.9 Million
Q3 2022

Nov 10, 2022

SELL
$123.79 - $277.42 $1.33 Million - $2.98 Million
-10,728 Reduced 8.15%
120,865 $27.2 Million
Q2 2022

Aug 12, 2022

SELL
$93.97 - $143.33 $4.73 Million - $7.22 Million
-50,370 Reduced 27.68%
131,593 $16.6 Million
Q1 2022

May 13, 2022

SELL
$98.9 - $132.37 $1.95 Million - $2.61 Million
-19,694 Reduced 9.77%
181,963 $23.1 Million
Q4 2021

Feb 09, 2022

BUY
$110.64 - $159.4 $2.19 Million - $3.16 Million
19,801 Added 10.89%
201,657 $26.4 Million
Q3 2021

Nov 12, 2021

BUY
$101.2 - $125.87 $7.57 Million - $9.41 Million
74,753 Added 69.8%
181,856 $22.2 Million
Q2 2021

Aug 12, 2021

BUY
$107.45 - $135.95 $11.5 Million - $14.6 Million
107,103 New
107,103 $12.2 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.